Skowronski DM - Search Results

1

Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.

Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Belongia EA, et al. Among authors: skowronski dm. Expert Rev Vaccines. 2017 Jul;16(7):1-14. doi: 10.1080/14760584.2017.1334554. Epub 2017 Jun 9. Expert Rev Vaccines. 2017. PMID: 28562111 Review.

2

The changing age and seasonal profile of pertussis in Canada.

Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, Champagne S, Patrick DM, Halperin SA. Skowronski DM, et al. J Infect Dis. 2002 May 15;185(10):1448-53. doi: 10.1086/340280. Epub 2002 Apr 22. J Infect Dis. 2002. PMID: 11992280

3

Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.

Skowronski DM, De Serres G, Hebert J, Stark D, Warrington R, Macnabb J, Shadmani R, Rochette L, MacDonald D, Patrick DM, Duval B. Skowronski DM, et al. Vaccine. 2002 Jun 21;20(21-22):2713-9. doi: 10.1016/s0264-410x(02)00214-1. Vaccine. 2002. PMID: 12034097

4

Low risk of recurrence of oculorespiratory syndrome following influenza revaccination.

Skowronski DM, Strauss B, Kendall P, Duval B, De Serres G. Skowronski DM, et al. CMAJ. 2002 Oct 15;167(8):853-8. CMAJ. 2002. PMID: 12406942 Free PMC article.

5

Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?

Skowronski DM, Lu H, Warrington R, Hegele RG, De Serres G, HayGlass K, Stark D, White R, Macnabb J, Li Y, Manson HE, Brunham RC. Skowronski DM, et al. J Infect Dis. 2003 Feb 1;187(3):495-9. doi: 10.1086/368117. Epub 2003 Jan 24. J Infect Dis. 2003. PMID: 12552434

6

Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications.

Scheifele D, Duval B, De Serres G, Skowronski DM. Scheifele D, et al. Among authors: skowronski dm. Control Clin Trials. 2003 Feb;24(1):99-104. doi: 10.1016/s0197-2456(02)00269-6. Control Clin Trials. 2003. PMID: 12559648

7

Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?

Skowronski DM, Strauss B, De Serres G, MacDonald D, Marion SA, Naus M, Patrick DM, Kendall P. Skowronski DM, et al. Clin Infect Dis. 2003 Mar 15;36(6):705-13. doi: 10.1086/367667. Epub 2003 Mar 5. Clin Infect Dis. 2003. PMID: 12627354

8

Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.

Scheifele DW, Duval B, Russell ML, Warrington R, DeSerres G, Skowronski DM, Dionne M, Kellner J, Davies D, MacDonald J. Scheifele DW, et al. Among authors: skowronski dm. Clin Infect Dis. 2003 Apr 1;36(7):850-7. doi: 10.1086/368189. Epub 2003 Mar 18. Clin Infect Dis. 2003. PMID: 12652385 Clinical Trial.

9

The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination.

De Serres G, Grenier JL, Toth E, Ménard S, Roussel R, Tremblay M, Fradet MD, Landry M, Robert Y, Skowronski DM. De Serres G, et al. Among authors: skowronski dm. Vaccine. 2003 Jun 2;21(19-20):2354-61. doi: 10.1016/s0264-410x(03)00094-x. Vaccine. 2003. PMID: 12744866

10

Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.

Skowronski DM, De Serres G, Scheifele D, Russell ML, Warrington R, Davies HD, Dionne M, Duval B, Kellner J, MacDonald J. Skowronski DM, et al. Clin Infect Dis. 2003 Oct 15;37(8):1059-66. doi: 10.1086/378274. Epub 2003 Sep 26. Clin Infect Dis. 2003. PMID: 14523770 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page